Drs Richard Champlin, Jerome Ritz, Willem Fibbe, Per Ljungman, and Malcom K. Brenner join Kerry Atkinson as editors of this definitive reference on the clinical practice and underlying science of hematopoietic stem cell transplantation. This third edition

Pages: 300, Hardcover, Praeger

All Products. Living Related Transplantation

Objective 1: For children who develop graft failure following cardiac transplantation retransplantation is often considered. While some centers have reported equivalent results for retransplantation as compared to primary transplantation this ...

Enterococci, especially vancomycin resistant enterococci (VRE), are increasing in prevalence in many hospitals in the United States. Patients undergoing liver transplantation are at particular risk for developing infection due to VRE. The effect of ...

Until recently HIV infection was considered as a contraindication for liver transplantation. A dramatic improvement in survival of HIV patients have been observed since the advent of new antiviral treatments against HIV including antiproteases. ...

BACKGROUND:Allogeneic bone marrow transplantation is an accepted therapeutic option for many hematologic immunologic and malignant diseases including chronic myelocytic leukemia and acute leukemia during or after first relapse (second remission). In ...

This study is a multicentre open-label prospective 2-arm phase IV study of tacrolimus in renal transplant recipients. Patients will be randomized to receive current clinical practice or to have a pre-transplant pharmacokinetic assessment of ...

A: Study groupFK506-MMF.Immunosupression protocol:Metylprednisolon 10 mg/kg intraoperatively ivFK506 Day 0 or 1 oraly (0 15 mg/kg/D in two doses).MMF max. dosage 30 mg/kg/D po day 0 through day 90 according to patient condition and therapeutic MMF ...

OBJECTIVES:- Determine if a one-year disease free survival of 40% and a day 200 transplant-related mortality of less than 25% can be achieved in patients with high-risk acute lymphoblastic leukemia in complete remission treated with a ...